International Journal of Molecular Sciences (May 2022)

Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6

  • Romina Cabrera-Rodríguez,
  • Silvia Pérez-Yanes,
  • Rafaela Montelongo,
  • José M. Lorenzo-Salazar,
  • Judith Estévez-Herrera,
  • Jonay García-Luis,
  • Antonio Íñigo-Campos,
  • Luis A. Rubio-Rodríguez,
  • Adrián Muñoz-Barrera,
  • Rodrigo Trujillo-González,
  • Roberto Dorta-Guerra,
  • Concha Casado,
  • María Pernas,
  • Julià Blanco,
  • Carlos Flores,
  • Agustín Valenzuela-Fernández

DOI
https://doi.org/10.3390/ijms23116180
Journal volume & issue
Vol. 23, no. 11
p. 6180

Abstract

Read online

The transactive response DNA-binding protein (TARDBP/TDP-43) influences the processing of diverse transcripts, including that of histone deacetylase 6 (HDAC6). Here, we assessed TDP-43 activity in terms of regulating CD4+ T-cell permissivity to HIV-1 infection. We observed that overexpression of wt-TDP-43 increased both mRNA and protein levels of HDAC6, resulting in impaired HIV-1 infection independently of the viral envelope glycoprotein complex (Env) tropism. Consistently, using an HIV-1 Env-mediated cell-to-cell fusion model, the overexpression of TDP-43 levels negatively affected viral Env fusion capacity. Silencing of endogenous TDP-43 significantly decreased HDAC6 levels and increased the fusogenic and infection activities of the HIV-1 Env. Using pseudovirus bearing primary viral Envs from HIV-1 individuals, overexpression of wt-TDP-43 strongly reduced the infection activity of Envs from viremic non-progressors (VNP) and rapid progressors (RP) patients down to the levels of the inefficient HIV-1 Envs observed in long-term non-progressor elite controllers (LTNP-EC). On the contrary, silencing endogenous TDP-43 significantly favored the infectivity of primary Envs from VNP and RP individuals, and notably increased the infection of those from LTNP-EC. Taken together, our results indicate that TDP-43 shapes cell permissivity to HIV-1 infection, affecting viral Env fusion and infection capacities by altering the HDAC6 levels and associated tubulin-deacetylase anti-HIV-1 activity.

Keywords